Company intelligence / Profile preview

EGB Advisors

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

EGB Advisors is a boutique life sciences advisory and investment firm that provides strategic, financial, and operational guidance to the biotechnology and pharmaceutical industries. Founded by Dr. Eli Borger, the firm specializes in asset-centric development, helping to identify and advance therapeutic programs from early-stage research through clinical proof-of-concept. EGB Advisors often takes an active role in company formation and has been instrumental in the launch of several precision medicine and oncology-focused startups. Their services include portfolio prioritization, licensing support, and capital formation strategies for the healthcare sector. The firm leverages deep industry expertise to bridge the gap between scientific innovation and commercial execution.

Industry: Consulting

Beyond the preview

Go deeper on EGB Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGB Advisors.

Explore the full profile